These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 32787955)

  • 1. Amyloid precursor protein glycosylation is altered in the brain of patients with Alzheimer's disease.
    Boix CP; Lopez-Font I; Cuchillo-Ibañez I; Sáez-Valero J
    Alzheimers Res Ther; 2020 Aug; 12(1):96. PubMed ID: 32787955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decrease in brain soluble amyloid precursor protein β (sAPPβ) in Alzheimer's disease cortex.
    Wu G; Sankaranarayanan S; Hsieh SH; Simon AJ; Savage MJ
    J Neurosci Res; 2011 Jun; 89(6):822-32. PubMed ID: 21433051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heteromers of amyloid precursor protein in cerebrospinal fluid.
    Cuchillo-Ibañez I; Lopez-Font I; Boix-Amorós A; Brinkmalm G; Blennow K; Molinuevo JL; Sáez-Valero J
    Mol Neurodegener; 2015 Jan; 10():2. PubMed ID: 25573162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CNS amyloid-β, soluble APP-α and -β kinetics during BACE inhibition.
    Dobrowolska JA; Michener MS; Wu G; Patterson BW; Chott R; Ovod V; Pyatkivskyy Y; Wildsmith KR; Kasten T; Mathers P; Dancho M; Lennox C; Smith BE; Gilberto D; McLoughlin D; Holder DJ; Stamford AW; Yarasheski KE; Kennedy ME; Savage MJ; Bateman RJ
    J Neurosci; 2014 Jun; 34(24):8336-46. PubMed ID: 24920637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiological mouse brain Abeta levels are not related to the phosphorylation state of threonine-668 of Alzheimer's APP.
    Sano Y; Nakaya T; Pedrini S; Takeda S; Iijima-Ando K; Iijima K; Mathews PM; Itohara S; Gandy S; Suzuki T
    PLoS One; 2006 Dec; 1(1):e51. PubMed ID: 17183681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble amyloid precursor protein α and β in CSF in Alzheimer's disease.
    Brinkmalm G; Brinkmalm A; Bourgeois P; Persson R; Hansson O; Portelius E; Mercken M; Andreasson U; Parent S; Lipari F; Ohrfelt A; Bjerke M; Minthon L; Zetterberg H; Blennow K; Nutu M
    Brain Res; 2013 Jun; 1513():117-26. PubMed ID: 23541617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of APP pathway mRNAs and proteins in Alzheimer's disease.
    Matsui T; Ingelsson M; Fukumoto H; Ramasamy K; Kowa H; Frosch MP; Irizarry MC; Hyman BT
    Brain Res; 2007 Aug; 1161():116-23. PubMed ID: 17586478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective Alzheimer's disease-associated APP A673T variant predominantly decreases sAPPβ levels in cerebrospinal fluid and 2D/3D cell culture models.
    Wittrahm R; Takalo M; Kuulasmaa T; Mäkinen PM; Mäkinen P; Končarević S; Fartzdinov V; Selzer S; Kokkola T; Antikainen L; Martiskainen H; Kemppainen S; Marttinen M; Jeskanen H; Rostalski H; Rahunen E; Kivipelto M; Ngandu T; Natunen T; Lambert JC; Tanzi RE; Kim DY; Rauramaa T; Herukka SK; Soininen H; Laakso M; Pike I; Leinonen V; Haapasalo A; Hiltunen M
    Neurobiol Dis; 2023 Jun; 182():106140. PubMed ID: 37120095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and neurobiological correlates of soluble amyloid precursor proteins in the cerebrospinal fluid.
    Alexopoulos P; Tsolakidou A; Roselli F; Arnold A; Grimmer T; Westerteicher C; Leante MR; Förstl H; Livrea P; Kurz A; Perneczky R
    Alzheimers Dement; 2012 Jul; 8(4):304-11. PubMed ID: 22055653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The alternatively spliced Kunitz protease inhibitor domain alters amyloid beta protein precursor processing and amyloid beta protein production in cultured cells.
    Ho L; Fukuchi Ki; Younkin SG
    J Biol Chem; 1996 Nov; 271(48):30929-34. PubMed ID: 8940079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. sAPPβ and sAPPα increase structural complexity and E/I input ratio in primary hippocampal neurons and alter Ca
    Hesse R; von Einem B; Wagner F; Bott P; Schwanzar D; Jackson RJ; Föhr KJ; Lausser L; Kroker KS; Proepper C; Walther P; Kestler HA; Spires-Jones TL; Boeckers T; Rosenbrock H; von Arnim CAF
    Exp Neurol; 2018 Jun; 304():1-13. PubMed ID: 29466703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diurnal patterns of soluble amyloid precursor protein metabolites in the human central nervous system.
    Dobrowolska JA; Kasten T; Huang Y; Benzinger TL; Sigurdson W; Ovod V; Morris JC; Bateman RJ
    PLoS One; 2014; 9(3):e89998. PubMed ID: 24646516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The apolipoprotein receptor LRP3 compromises APP levels.
    Cuchillo-Ibañez I; Lennol MP; Escamilla S; Mata-Balaguer T; Valverde-Vozmediano L; Lopez-Font I; Ferrer I; Sáez-Valero J
    Alzheimers Res Ther; 2021 Nov; 13(1):181. PubMed ID: 34727970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Absence of Myelin Basic Protein Reduces Non-Amyloidogenic Processing of Amyloid Precursor Protein.
    Seiwa C; Sugiyama I; Sugawa M; Murase H; Kudoh C; Asou H
    Curr Alzheimer Res; 2021; 18(4):326-334. PubMed ID: 34218780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic Cerebral Hypoperfusion Promotes Amyloid-Beta Pathogenesis via Activating β/γ-Secretases.
    Cai Z; Liu Z; Xiao M; Wang C; Tian F
    Neurochem Res; 2017 Dec; 42(12):3446-3455. PubMed ID: 28836062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute interleukin-6 modulates key enzymes involved in prefrontal cortex and hippocampal amyloid precursor protein processing.
    Marko DM; Finch MS; Yang AJT; Castellani LN; Peppler WT; Wright DC; MacPherson REK
    J Appl Physiol (1985); 2023 May; 134(5):1115-1123. PubMed ID: 36892889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevation of plasma soluble amyloid precursor protein beta in Alzheimer's disease.
    Yun SM; Cho SJ; Jo C; Park MH; Han C; Koh YH
    Arch Gerontol Geriatr; 2020; 87():103995. PubMed ID: 31874328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of plasma β-secretase (BACE1) activity and soluble amyloid precursor proteins as potential biomarkers for Alzheimer's disease.
    Wu G; Sankaranarayanan S; Wong J; Tugusheva K; Michener MS; Shi X; Cook JJ; Simon AJ; Savage MJ
    J Neurosci Res; 2012 Dec; 90(12):2247-58. PubMed ID: 22987781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of phenothiazine-structured compounds on APP processing in Alzheimer's disease cellular model.
    Yuksel M; Biberoglu K; Onder S; Akbulut KG; Tacal O
    Biochimie; 2017 Jul; 138():82-89. PubMed ID: 28457944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryptotanshinone, a compound from Salvia miltiorrhiza modulates amyloid precursor protein metabolism and attenuates beta-amyloid deposition through upregulating alpha-secretase in vivo and in vitro.
    Mei Z; Zhang F; Tao L; Zheng W; Cao Y; Wang Z; Tang S; Le K; Chen S; Pi R; Liu P
    Neurosci Lett; 2009 Mar; 452(2):90-5. PubMed ID: 19154776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.